Table 6.

Combined mutation carriers that have obtained surgical pathological results in this study.

Sample	Sex	Age	Bethesda	Disease manifestation	Molecular change
C-006	Female	58	II	Follicular adenoma	PTEN I135Mfs*44/PTEN C124F
C-007	Female	32	VI	Papillary thyroid carcinoma (CPTC+TVCPTC)	BRAF V600E/PIK3CA H1047Y
C-013	Female	53	IV	Papillary thyroid carcinoma	NRAS Q61R/TERT C228T
C-014	Female	37	VI	Papillary carcinoma (CPTC+TVCPTC)	PTEN L140Ffs*6/PTEN R173P
C-020	Male	48	VI	Papillary thyroid carcinoma	BRAF V600E/PIK3CA H1047R
C-026	Female	31	V	Papillary thyroid carcinoma	BRAF V600E/RET N783S
C-029	Female	30	VI	Papillary thyroid carcinoma	BRAF V600E/TERT C228T
C-044	Male	57	VI	Papillary thyroid carcinoma (CPTC+TVCPTC)	BRAF V600E/TP53 R248Q
C-421	Female	44	NA	Papillary thyroid carcinoma	BRAF V600E/TP53 R273H
C-455	Male	62	NA	Metastatic thyroid cancer	NRAS Q61R/TP53 C141Y/TERT C228T
C-456	Female	59	NA	Metastatic thyroid cancer	NRAS Q61K/TERT C228T/CCDC6(1)-RET(12)
C-463	Female	22	III	Recurrent thyroid cancer	PTEN R335*/TSHR L629F